Old CIC Events
06/06/2024
Aberrant fibrotic phenotypes of tumor-associated fibroblasts in lung cancer: translational opportunities
Jordi Alcaraz — Universitat de Barcelona
30/05/2024
Intercellular communication in the immune response: transfer of genetic information during synapsis
Francisco Sánchez-Madrid — Hospital Universitario de la Princesa. Universidad Autónoma de Madrid. CIBERCV.
22/05/2024
Decoding the Extracellular matrix at the immunosuppressive tumor microenvironment: the forgotten partner
Mª Jose Oliveira — i3S-Institute for Research and Innovation in Health, University of Porto, Portugal
16/05/2024
Artificial Intelligence to explore vast chemical spaces for drug leads
Pedro Ballester — Imperial College London
09/05/2024
Exploring and exploiting the vasculature in brain tumors
Leire Bejarano — Ludwig Institute for Cancer Research (LICR), Lausanne, Switzerland
25/04/2024
Oncolytic viruses for the treatment of pediatric brain tumors: The force awakens
Marta María Alonso Roldán — CIMA, Universidad de Navarra
18/04/2024
Cell of origin and molecular drivers of non-small cell lung cancer
Rocío Sotillo — German Cancer Research Center (DKFZ), Heidelberg (Germany)
11/04/2024
Impact of the hyperactivation of the C3G-Rap1 pathway in murine lymphoma cells
Alba Morán Vaquero — Centro de Investigación del Cáncer (CSIC-Universidad de Salamanca)
04/04/2024
Mitochondrial dysfunction in B cells: a driver of an aged immune response
Nuria Martínez-Martín — Centro De Biología Molecular Severo Ochoa
22/03/2024
Interrogating the Functional Landscape of Histone Post-Translational Modifications
Cristina Viéitez Manrique — Instituto de Biología Funcional y Genómica (IBFG), Salamanca.
14/03/2024
Analysis of the molecular mechanisms of genetic predisposition through the study of childhood leukemia
Marta Isidro — Centro de Investigación del Cáncer (CSIC-Universidad de Salamanca), Salamanca
07/03/2024
Uncovering the role of flavin-containing monooxygenase 4 in lung adenocarcinoma: a new protector against ferroptosis
Antonio Maraver — Montpellier Cancer Research Institute (IRCM), Montpellier, France